S Kironde1, M Meintjies. 1. Department of Public Health and Primary Care, Institute of Health Sciences, Oxford University, UK. skironde@hotmail.com
Abstract
SETTING: The Northern Cape Province, Republic of South Africa. OBJECTIVES: To determine the effect of patient choice of treatment delivery option on the treatment outcomes of tuberculosis (TB) patients in a high burden setting under actual programme conditions. DESIGN: Cohort study involving 769 new and retreatment TB patients recruited from 45 randomly selected clinics. Patients were interviewed and subsequent follow-up was done through regular visits to the clinics to check progress through formal health records. RESULTS: There was a statistically significant difference (P < 0.001) between the treatment outcome of new patients (70% successful) and re-treatment patients (54% successful). Direct observation of treatment (DOT) was found to have no effect on the treatment outcome of new patients (P = 0.875), but re-treatment patients were found to fare better with than without DOT (OR 14.2, 95% CI 4.18-53.14, P < 0.001). CONCLUSION: The results obtained for new patients are similar to those of two recent randomised controlled trials on DOT. This study revealed that for new patients, undue emphasis on universal DOT might be unnecessary. It would perhaps be more beneficial to target supervision at those patients who are most likely to benefit from it (i.e., re-treatment patients). This is of particular relevance in high burden, resource-limited settings where universal DOT for all TB patients is generally unfeasible.
SETTING: The Northern Cape Province, Republic of South Africa. OBJECTIVES: To determine the effect of patient choice of treatment delivery option on the treatment outcomes of tuberculosis (TB) patients in a high burden setting under actual programme conditions. DESIGN: Cohort study involving 769 new and retreatment TB patients recruited from 45 randomly selected clinics. Patients were interviewed and subsequent follow-up was done through regular visits to the clinics to check progress through formal health records. RESULTS: There was a statistically significant difference (P < 0.001) between the treatment outcome of new patients (70% successful) and re-treatment patients (54% successful). Direct observation of treatment (DOT) was found to have no effect on the treatment outcome of new patients (P = 0.875), but re-treatment patients were found to fare better with than without DOT (OR 14.2, 95% CI 4.18-53.14, P < 0.001). CONCLUSION: The results obtained for new patients are similar to those of two recent randomised controlled trials on DOT. This study revealed that for new patients, undue emphasis on universal DOT might be unnecessary. It would perhaps be more beneficial to target supervision at those patients who are most likely to benefit from it (i.e., re-treatment patients). This is of particular relevance in high burden, resource-limited settings where universal DOT for all TB patients is generally unfeasible.
Authors: A Almeida; M Adjuntsov; W Bushura; E Delgado; M Drasher; M Fernando-Pancho; M Gasane; M V Ianoşi; E Lessem; A Musah; Ş Răduţ; C H Sánchez Ríos; K S Soe; N Venkatesan; V V Villegas; J Stillo Journal: Public Health Action Date: 2021-09-21
Authors: Edward C Jones-López; Irene Ayakaka; Jonathan Levin; Nancy Reilly; Francis Mumbowa; Scott Dryden-Peterson; Grace Nyakoojo; Kevin Fennelly; Beth Temple; Susan Nakubulwa; Moses L Joloba; Alphonse Okwera; Kathleen D Eisenach; Ruth McNerney; Alison M Elliott; Jerrold J Ellner; Peter G Smith; Roy D Mugerwa Journal: PLoS Med Date: 2011-03-15 Impact factor: 11.069
Authors: Hannock Tweya; Henry Kanyerere; Anne Ben-Smith; John Kwanjana; Andreas Jahn; Caryl Feldacker; Dickman Gareta; Limbani Mbetewa; Mathew Kagoli; Mike Tikhalenawo Kalulu; Ralf Weigel; Sam Phiri; Mary Edginton Journal: PLoS One Date: 2011-12-14 Impact factor: 3.240
Authors: L V Adams; T S B Maseko; E A Talbot; S W Grande; M M Mkhontfo; Z Z Simelane; A A Achilla; S M Haumba Journal: Public Health Action Date: 2019-12-21